Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More
Xconomy
JULY 24, 2020
EQRx launched in January during the JP Morgan Healthcare Conference with an audacious pledge to create 10 new drugs in as many years and then sell them at “dramatically” lower prices than existing medicines. Both drugs are anti-cancer molecules in mid-stage development that have been designed to hit known cancer targets. But not much.
Let's personalize your content